Long-Term Testosterone Treatment Reduced HbA1c in Men With Hypogonadism and Type 2 Diabetes – Endocrinology Advisor

Posted: June 11, 2017 at 6:46 pm


Endocrinology Advisor
Long-Term Testosterone Treatment Reduced HbA1c in Men With Hypogonadism and Type 2 Diabetes
Endocrinology Advisor
Hypogonadal men with type 2 diabetes (T2D) who were treated with testosterone undecanoate (TU) injections demonstrated reductions in glycated hemoglobin A1c (HbA1c) and anthropometric measures, according to data presented at the 77th American …

and more »

Continue reading here:
Long-Term Testosterone Treatment Reduced HbA1c in Men With Hypogonadism and Type 2 Diabetes – Endocrinology Advisor

Related Post

Comments are closed.

Archives